ADGI News & Analysis

Adagio Medical (ADGI) Receives Nasdaq Notice for Bid Price Issue

Adagio Medical (ADGI) received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's stock price has remained below the $1 threshold for 30 consecutive trading days. Nasdaq has provided a 180-day compliance period for Adagio to regain compliance. This notice could impact investor sentiment and trading volume as the company works to meet exchange standards.